ArticleScientific reports2022

Age-related differences in the survival benefit of the administration of antithrombin, recombinant human thrombomodulin, or their combination in sepsis.

Takeshi Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.